OPTIMISMM: benefits of a new triplet therapy for MM patients relapsing on lenalidomide
Meletios Dimopoulos, MD, of the University of Athens School of Medicine, Athens, Greece, gives an overview of the OPTIMISMM trial (NCT01734928) at the 2018 Society of Hematologic Oncology (SOHO) Annua...
Author: VJHemOnc
Added: 09/19/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts